Results 81 to 90 of about 21,821,162 (213)

Integrated Engineering of CAR‐T Cells for Solid Tumours

Cell Proliferation, Volume 59, Issue 9, September 2026.
Solid tumours pose multifactorial barriers including antigen heterogeneity, immunosuppressive microenvironment, and poor T‐cell trafficking, limiting CAR‐T efficacy compared to hematologic malignancies. Integrated engineering strategies are essential, combining logic‐gated receptors for precision, metabolic‐epigenetic reprogramming for resilience, and ...
Chao Yang, Tan Li, Ping He, Zhijie Zhao, Shenglong Li, Liming Wang   +5 more
wiley   +1 more source

Evidence of interaction between HTLV-I and HTLV-II Tax proteins with RelA/p65 subunit of NF-kB complex

, 2007
Evidence of interaction between HTLV-I and HTLV-II Tax proteins with RelA/p65 subunit of NF-kB complex.
Bertazzoni U., LORENZI, Pamela, BERTAZZONI, Umberto, Avesani F., TURCI, Marco, ROMANELLI, Maria, BIDOIA, Carlo   +6 more
core   +1 more source

High Prevalence and Risk Factors for Infection with Human T-Lymphotropic Viruses 1 and 2 in the Municipality of Ananindeua, Pará, Northern Brazil

Viruses
This descriptive, observational, cross-sectional study evaluated HTLV-1 and HTLV-2 infections in Ananindeua, northern Brazil. Individuals were screened for anti-HTLV-1/2 using ELISA (Murex HTLV-I + II, DiaSorin).
Dara da Costa Soares, Felipe Teixeira Lopes, Gabriel dos Santos Pereira Neto, Luciana Cristina Coelho Pantoja Santos, Aline Cecy Rocha Lima, Bruno Sarmento Botelho, Isabella Nogueira Abreu, Felipe Bonfim Freitas, Ricardo Ishak, Izaura Maria Vieira Cayres Vallinoto, Antonio Carlos Rosário Vallinoto   +10 more
doaj   +1 more source

HTLV-1 prevalence according to age for 386 female and 334 male community residents.

, 2021
HTLV-1 infection was confirmed for 218 participants, using HTLV-1 western blots (WB) and/or HTLV-1 PCR (WB positive/PCR positive, 209; indeterminate WB/PCR positive, 8; tested by dried blood spot, PCR positive, 1).
Antoine Gessain (31917), Mohammad Radwanur Talukder (11812779), Richard Woodman (3905950), Lloyd Einsiedel (463667), Kim Wilson (90622), John Kaldor (613150), Kerry Taylor (11812782), Hai Pham (265646)   +7 more
core   +1 more source

Human T-cell Lymphotropic Virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology

Cadernos de Saúde Pública, 2003
We review here the epidemiological studies performed by our group on human retrovirus HTLV-I and HTLV-II infections and the associated diseases in French Guiana since 1984.
Kazanji Mirdad, Gessain Antoine
doaj  

Human T-lymphotropic virus 1/2 infection among prisoners of a major penitentiary complex of Goiás State, Central-West Brazil

Frontiers in Public Health
IntroductionStudies on human T-lymphotropic virus 1/2 (HTLV-1/2) infection are scarce in incarcerated population. Therefore, this study estimated the prevalence of HTLV-1/2 infection among prisoners of the major penitentiary complex of Goiás State ...
Michele Tiemi Okita, Marcos André de Matos, Nara Rúbia de Freitas, Ágabo Macedo da Costa e Silva, Juliana Menara de Souza Marques, Thaís Augusto Marinho, Márcia Alves Dias de Matos, Regina Maria Bringel Martins   +7 more
doaj   +1 more source

El HTLV-I y sus enfermedades asociadas [PDF]

, 2005
El virus T-linfotrópico humano tipo 1 (HTLV-I) fue el primer retrovirus humano identificado en la historia de la virología. La infección por HTLV-I es endémica en el sureste japonés, el Caribe, el sureste de los Estados Unidos, África y Suramérica ...
Wolff, Juan Carlos, Herrera, Silvia, Sanclemente, Gloria   +2 more
core  

Opportunistic Infections in Patients with HTLV-1 Infection [PDF]

, 2015
As an acquired immunodeficiency, human immunodeficiency virus (HIV) infection is primarily responsible for opportunistic infections in infected patients.
Shinsaku Imashuku, Masakatsu Usui, Toshiki Tanaka, Toshio Sekioka   +3 more
core   +1 more source

HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon

, 2017
A serosurvey for Human T-cell Lymphotropic virus type 1 (HTLV-I)/HTLV-II was conducted in 1,900 blood donors, 120 pregnant women and 436 high-risk group patients in Beirut, Lebanon.
Naboulsi, M., Mokhbat, J., Ramia, S., Klayme, S., Jradi, O., Naman, R.   +5 more
core   +1 more source

HTLV-1⁺ subject and uninfected volunteer samples used.

, 2023
HTLV-1+ subject and uninfected volunteer samples used.
David S. Rueda (7879094), Aris E. N. Aristodemou (16715714), Charles R. M. Bangham (7879097), Graham P. Taylor (6678695)   +3 more
core   +1 more source